An interventional study of HA in Pregnancy, High Risk, sponsored by Lo.Li.Pharma s.r.l. Completed at 1 site in Italy. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-03.
Sponsored by Lo.Li.Pharma s.r.l · Not applicable, Interventional, and Prevention
The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion.
Lo.Li.Pharma s.r.l is the lead sponsor of 30 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Women with risk factors for abortion, treated with progesterone
Women with risk factors for abortion, treated with progesterone and a dietary supplement containing hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6
Dietary Supplement: HA
hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6
reduction of the abortion rate
rate of abortion
Time frame: 1 day (single time-point before week 20 of gestation)
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lo.Li.Pharma s.r.l